Cargando…
Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study
INTRODUCTION: This study explored the ability of plasma amyloid beta (Aβ)42/Aβ40 to identify brain amyloid deposition in cognitively unimpaired (CU) individuals. METHODS: Plasma Aβ was quantified with an antibody‐free high‐performance liquid chromatography tandem mass spectrometry method from Araclo...
Autores principales: | Allué, José Antonio, Pascual‐Lucas, María, Sarasa, Leticia, Castillo, Sergio, Sarasa, Manuel, Sáez, María Eugenia, Abdel‐Latif, Sara, Rissman, Robert A., Terencio, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236000/ https://www.ncbi.nlm.nih.gov/pubmed/37274930 http://dx.doi.org/10.1002/dad2.12451 |
Ejemplares similares
-
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease
por: Allué, José Antonio, et al.
Publicado: (2016) -
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
por: Pascual-Lucas, María, et al.
Publicado: (2023) -
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023) -
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
por: Jang, Hyemin, et al.
Publicado: (2021) -
Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94
por: Michalowska, Malgorzata M., et al.
Publicado: (2022)